当前位置：首页 > 文献互助 > 互助详情

期刊论文Oral PCSK9 inhibitor enlicitide lowers LDL cholesterol levels in phase 2 trial复制

用户ilD0IKN71DDA 1小时前 22 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-04-03 12:07:01 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

其他信息:

出版社: Springer Science and Business Media LLC
作者: Xiulin Koehler
全文下载地址: https://www.nature.com/articles/s44161-026-00794-7.pdf

互助时间线

楼主确认了文献探秘应助的文件是正确的, 求助状态变成已完结

文献探秘上传了文件(pdf 528.72 KB), 求助状态变成待确认

Room‐Temperature Nucleophilic Aromatic Fluorination: Experimental and Theoretical Studies 10分钟前

Predictors of histologic response to mepolizumab in pediatric eosinophilic esophagitis 25分钟前

Safety and Efficacy of Oral PCSK9 Inhibitors in Hypercholesterolemia: A Systematic Review and Network Meta-Analysis 1小时前

MG-K10, a Long-Acting Anti-IL-4 Receptor Alpha Monoclonal Antibody in Adult Patients with Moderate-to-Severe Atopic Dermatitis 1小时前

Oral PCSK9 inhibitor enlicitide lowers LDL cholesterol levels in phase 2 trial 1小时前

Potential Biomedical Applications of Terbium-Based Nanoparticles (TbNPs): A Review on Recent Advancement 2小时前

Protein-based active films: Raw materials, functions, and food applications 2小时前